Myeloablative vs non-myeloablative conditioning with allogeneic stem cell transplantation for high risk now Hodgkin's lymphoma: Similar outcomes despite differences in disease risk

被引：0
|
作者：
Hewitt, M [1 ]
Porter, DL [1 ]
Hummel, K [1 ]
McAlee, A [1 ]
Phillips, J [1 ]
Stadtmauer, E [1 ]
Schuster, S [1 ]
Luger, S [1 ]
Nasta, S [1 ]
Tsai, D [1 ]
Loren, A [1 ]
Perl, A [1 ]
Emerson, S [1 ]
Goldstein, SC [1 ]
机构：
[1] Univ Penn, Blood & Marrow Stem Cell Transplant Program, Philadelphia, PA 19104 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
79
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [1] Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease
    Hovgaard, Doris
    Sengelov, Henrik
    Vindelov, Lars
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S197 - S197
  • [2] Non-myeloablative allogeneic stem cell transplantation in patients with high-risk lymphoma: a multicentre experience
    Console, G.
    Irrera, G.
    Martino, M.
    Messina, G.
    Pucci, G.
    Moscato, T.
    Fedele, R.
    Massara, E.
    Cuzzola, M.
    Pontari, A.
    Callea, I.
    Dattola, A.
    Garreffa, C.
    Spiniello, E.
    Meliado, A.
    Rigolino, C.
    Del Vecchio, T.
    Iacopino, O.
    Cannata, M. C.
    Scaramozzino, P.
    Bova, I.
    Marcuccio, D.
    Stelitano, C.
    Molica, S.
    Cantaffa, R.
    Nocilli, L.
    Mele, A.
    Pavone, V.
    Abbadessa, A.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S388 - S388
  • [3] Tandem Autologous/Non-Myeloablative Allogeneic Transplantation for High Risk Non-Hodgkin Lymphoma (NHL)
    Fakhri, Bita
    Cashen, Amanda
    Comer, Holly
    Abboud, Camille
    Westervelt, Peter
    DiPersio, John E.
    Stockerl-Goldstein, Keith
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S300 - S300
  • [4] Non-myeloablative conditioning with allogeneic progenitor cell transplantation for relapsed Hodgkin's lymphoma: High response rate despite prior chemoresistance.
    Goldstein, SC
    Luger, SM
    Stadtmauer, E
    Schuster, S
    Tsai, D
    Nasta, S
    Loren, A
    Perl, A
    Orloff, G
    Oliver, J
    Sachs, R
    Emerson, S
    Porter, DL
    BLOOD, 2004, 104 (11) : 621A - 622A
  • [5] Non-myeloablative allogeneic stem cell transplantation in mantle cell lymphoma
    Le Gouill, S.
    Kroeger, N.
    Dhedin, N.
    Nagler, A.
    Bouabdallah, K.
    Yakoub-Agha, I.
    Bulabois, C-E
    Buzyn, A.
    Rio, B.
    Moles, M-P.
    Shimoni, A.
    Guillaume, T.
    Milpied, N.
    Leux, C.
    Harousseau, J-L.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S67 - S67
  • [6] NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION (NST) IN PATIENTS WITH HIGH RISK LYMPHOMA: A SINGLE CENTRE EXPERIENCE
    Console, Giuseppe
    Messina, Giuseppe
    Martino, Massimo
    Morabito, Fortunato
    Irrera, Giuseppe
    Pucci, Giulia
    Penna, Giuseppa
    Cuzzola, Maria
    Iacopino, Olga
    Stelitano, Caterina
    Callea, Vincenzo
    Mamone, Domenico
    Kropp, Maria Grazia
    Molica, Stefano
    Abbadessa, Antonio
    Iacopino, Pasquale
    ANNALS OF ONCOLOGY, 2004, 15 : 79 - 79
  • [7] Risk for cytomegalovirus infection following non-myeloablative allogeneic stem cell transplantation
    Nachbaur, D
    Gunsilius, E
    Haun, M
    Larcher, C
    Gastl, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S96 - S97
  • [8] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
  • [9] High risk of acute pulmonary toxicity with both myeloablative and non-myeloablative total body irradiation-based conditioning for allogeneic stem cell transplantation
    Patel, Pranalee
    Dillon, Mairead
    Niedzwiecki, Donna
    Crowell, Kerri-Anne
    Horwitz, Mitchell E.
    Wang, Edina
    Kelsey, Chris R.
    BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 150 - 152
  • [10] High risk of acute pulmonary toxicity with both myeloablative and non-myeloablative total body irradiation-based conditioning for allogeneic stem cell transplantation
    Pranalee Patel
    Mairead Dillon
    Donna Niedzwiecki
    Kerri-Anne Crowell
    Mitchell E. Horwitz
    Edina Wang
    Chris R. Kelsey
    Bone Marrow Transplantation, 2024, 59 : 150 - 152
12345